DBV Technologies

DBVT

DBVT DBV Technologies NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    DBVT Chart
    See on advanced chart >

    About

    Dbv Technologies S.A. is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The company's therapeutic approach is based on epicutaneous immunotherapy,...
    • Highlight
      A developer of therapeutics based on epicutaneous immunotherapy to treat severe food allergies
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      10/22/2014
    • Established Date
      03/29/2002
    • Full-time Employees
      85
    • Address
      177-181 avenue Pierre Brossolette Montrouge 92120 France
    • Tel
      33-1-55427878
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)
    cache time: 2024-02-23 13:23:14